Aurobindo Pharma Limited (NSE:AUROPHARMA)

Aurobindo Pharma Revenue

In the fiscal year ending March 31, 2026, Aurobindo Pharma had annual revenue of 336.53B INR with 6.08% growth. Aurobindo Pharma had revenue of 88.53B in the quarter ending March 31, 2026, with 5.62% growth.

• Revenue: 336.53B
• Revenue Growth: +6.08%
• P/S Ratio: 2.56
• Revenue / Employee: 12.15M
• Employees: 27,707
• Market Cap: 861.80B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	336.53B	19.29B	6.08%
Mar 31, 2025	317.24B	27.22B	9.39%
Mar 31, 2024	290.02B	41.46B	16.68%
Mar 31, 2023	248.55B	14.00B	5.97%
Mar 31, 2022	234.55B	-13.19B	-5.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error